Tag: NASH treatment

Browse exclusive Tags!

Madrigal Pharmaceuticals Stock Rises 5% as Company Commences FDA Submission for NASH Treatment Approval

Madrigal Pharmaceuticals' stock surges 5% as it begins the rolling submission of NDA for resmetirom, a potential treatment for NASH with liver fibrosis.

Popular

Subscribe

spot_imgspot_img